DIMENIUM 50 mikrogramov/250 mikrogramov/dávka Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimenium 50 mikrogramov/250 mikrogramov/dávka

elpen pharmaceutical co.inc (sa), grécko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

DOTAREM 0,5 mmol/ml injekčný roztok naplnený v injekčnej striekačke Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dotarem 0,5 mmol/ml injekčný roztok naplnený v injekčnej striekačke

guerbet, francúzsko - kyselina gadoterová - 48 - diagnostica

DELPARAN 75 mg/650 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

delparan 75 mg/650 mg tablety

sandoz pharmaceuticals d.d., slovinsko - tramadol a paracetamol - 65 - analgetica - anodyna

DELPARAN 37,5 mg/325 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

delparan 37,5 mg/325 mg tablety

sandoz pharmaceuticals d.d., slovinsko - tramadol a paracetamol - 65 - analgetica - anodyna

Ezetimib Teva 10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ezetimib teva 10 mg

teva pharmaceuticals slovakia s.r.o., slovensko - ezetimib - 31 - hypolipidaemica

Nebivolol Krka 5 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nebivolol krka 5 mg tablety

krka, d.d., novo mesto, slovinsko - nebivolol - 58 - hypotensiva

Ervebo Európska únia - slovenčina - EMA (European Medicines Agency)

ervebo

merck sharp & dohme b.v.  - rekombinantnej vírus vezikulárnej stomatitídy (kmeň indiana) s odstránením obálky glykoproteín, v súlade s zair ebolavirus (kmeň kikwit 1995) povrch glykoproteín - hemorrhagic fever, ebola - vakcíny - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. použitie ervebo by mali byť v súlade s oficiálne odporúčania.

Temybric Ellipta Európska únia - slovenčina - EMA (European Medicines Agency)

temybric ellipta

glaxosmithkline trading services limited - flutikazón furoát, umeklidínium bromid, vilanterol trifenát - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - temybric ellipta je uvedené ako udržiavaciu liečbu u dospelých pacientov so stredne ťažkou až ťažkou chronickou obštrukčnou chorobou (chochp), ktorí nie sú dostatočne liečení kombináciou inhalačných kortikosteroidov a dlhodobo pôsobiaci β2-agonist alebo kombináciou dlho-pôsobiace β2-agonist a dlho-úradujúci muškárov antagonista (pre účinky na príznak kontrolu a prevenciu exacerbations pozri časť 5.

Lumeblue (previously known as Methylthioninium chloride Cosmo) Európska únia - slovenčina - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metyltioníniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Comirnaty Európska únia - slovenčina - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.